94 related articles for article (PubMed ID: 25151031)
1. The effects of improved metabolic risk factors on bone turnover markers after 12 weeks of simvastatin treatment with or without exercise.
Jiang J; Boyle LJ; Mikus CR; Oberlin DJ; Fletcher JA; Thyfault JP; Hinton PS
Metabolism; 2014 Nov; 63(11):1398-408. PubMed ID: 25151031
[TBL] [Abstract][Full Text] [Related]
2. The acute effects of exercise on bone turnover.
Welsh L; Rutherford OM; James I; Crowley C; Comer M; Wolman R
Int J Sports Med; 1997 May; 18(4):247-51. PubMed ID: 9231839
[TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
Rejnmark L; Buus NH; Vestergaard P; Heickendorff L; Andreasen F; Larsen ML; Mosekilde L
J Bone Miner Res; 2004 May; 19(5):737-44. PubMed ID: 15068496
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
[TBL] [Abstract][Full Text] [Related]
5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
6. Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
Lazich I; Sarafidis P; de Guzman E; Patel A; Oliva R; Bakris G
Diabetes Obes Metab; 2012 Feb; 14(2):181-6. PubMed ID: 21955403
[TBL] [Abstract][Full Text] [Related]
7. Thalassemic osteopathy: a new marker of bone deposition.
Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
[TBL] [Abstract][Full Text] [Related]
8. Acute response of plasma markers of bone turnover to a single bout of resistance training or plyometrics.
Rogers RS; Dawson AW; Wang Z; Thyfault JP; Hinton PS
J Appl Physiol (1985); 2011 Nov; 111(5):1353-60. PubMed ID: 21868687
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.
Tikiz C; Tikiz H; Taneli F; Gümüşer G; Tüzün C
Clin Rheumatol; 2005 Sep; 24(5):447-52. PubMed ID: 15742122
[TBL] [Abstract][Full Text] [Related]
10. Effects of statins on biomarkers of bone metabolism: a randomised trial.
Stein EA; Farnier M; Waldstreicher J; Mercuri M;
Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):84-7. PubMed ID: 11434192
[TBL] [Abstract][Full Text] [Related]
11. Short-term reduction in bone markers with high-dose simvastatin.
Rosenson RS; Tangney CC; Langman CB; Parker TS; Levine DM; Gordon BR
Osteoporos Int; 2005 Oct; 16(10):1272-6. PubMed ID: 16088363
[TBL] [Abstract][Full Text] [Related]
12. Correlation between salivary and serum markers of bone turnover in osteopenic rats.
Pellegrini GG; Gonzales CM; Somoza JC; Friedman SM; Zeni SN
J Periodontol; 2008 Jan; 79(1):158-65. PubMed ID: 18166106
[TBL] [Abstract][Full Text] [Related]
13. Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease.
Gupta M; Szmitko PE; Tsigoulis M; Braga MF; Kajil M; Herjikaka S; Quan A; Teoh H; Verma S
J Cardiovasc Pharmacol; 2010 Sep; 56(3):241-5. PubMed ID: 20505518
[TBL] [Abstract][Full Text] [Related]
14. Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
Chuengsamarn S; Rattanamongkoulgul S; Suwanwalaikorn S; Wattanasirichaigoon S; Kaufman L
Bone; 2010 Apr; 46(4):1011-5. PubMed ID: 20045497
[TBL] [Abstract][Full Text] [Related]
15. Statins decrease bone turnover in postmenopausal women: a cross-sectional study.
Rejnmark L; Buus NH; Vestergaard P; Andreasen F; Larsen ML; Mosekilde L
Eur J Clin Invest; 2002 Aug; 32(8):581-9. PubMed ID: 12190958
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of a supplemented milk drink on bone metabolism in healthy postmenopausal women is influenced by the metabolic syndrome.
Thomas SD; Morris HA; Nordin BE
Nutr J; 2015 Sep; 14():99. PubMed ID: 26407553
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone turnover induced by aerobic and anaerobic exercise in young males.
Woitge HW; Friedmann B; Suttner S; Farahmand I; Müller M; Schmidt-Gayk H; Baertsch P; Ziegler R; Seibel MJ
J Bone Miner Res; 1998 Dec; 13(12):1797-804. PubMed ID: 9844096
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
19. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
20. Bone protective effect of simvastatin in experimental arthritis.
Funk JL; Chen J; Downey KJ; Clark RA
J Rheumatol; 2008 Jun; 35(6):1083-91. PubMed ID: 18464303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
